Showing results (51-60 of 100) with videos related to
Sort By:
Pageof 10
The Journal of Clinical Psychiatry|November 6, 2002
Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch studyJean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, et al.Journal of Clinical Psychopharmacology|September 4, 2010
Paliperidone extended-release in schizoaffective disorder: a randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizersCarla M Canuso, Nina Schooler, Jennifer Carothers, et al.The Journal of Clinical Psychiatry|January 28, 2004
Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidolJan Volavka, Pal Czobor, Thomas B Cooper, et al.Journal of Psychiatric Research|October 27, 2004
Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorderKaren A Nolan, Jan Volavka, Pal Czobor, et al.Schizophrenia Research|April 22, 2004
An excitement subscale of the Positive and Negative Syndrome ScaleJean-Pierre Lindenmayer, Eileen Brown, Robert W Baker, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 13, 2013
Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phasesRobert A Lasser, Bryan Dirks, Henry Nasrallah, et al.Journal of Clinical Psychopharmacology|May 18, 2010
A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophreniaGahan J Pandina, Jean-Pierre Lindenmayer, Julia Lull, et al.CNS Spectrums|May 19, 2020
A long-term, open-label study of valbenazine for tardive dyskinesiaJean-Pierre Lindenmayer, Cherian Verghese, Stephen R Marder, et al.Schizophrenia Bulletin|November 6, 2012
Improving social cognition in schizophrenia: a pilot intervention combining computerized social cognition training with cognitive remediationJean-Pierre Lindenmayer, Susan R McGurk, Anzalee Khan, et al.Patient Preference and Adherence|July 20, 2017
Access to credible information on schizophrenia patients' medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providersJason Shafrin, Suepattra G May, Anshu Shrestha, et al.Pageof 10